Eligo Bioscience
Series BFranceDec 2023
Eligo Bioscience raised €28M in a Series B round in Dec 2023. The company is based in France. Investors in the round: Bpifrance, Khosla Ventures, Sanofi Ventures and 1 other. Data as of Nov 2026.
Amount raised
€28M
€27,700,000
Native amount
27,700,000 EUR
Stage
Series B
series b
Investors
4
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €28M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Dec 2023
Round type
series b
Amount (EUR)
€28M